Comment from The Geneva Foundation, HHS-OPHS-2018-0021, HHS-OPHS-2018-0021-0001, N/A

Summary: MiMedx Group, Inc. is submitting a clinical trial informed consent document for a phase 2B study on the treatment of osteoarthritis of the knee. The submission appears to be a fulfillment of the posting requirement rather than a comment expressing a position on the rule itself.